Table of Contents PART 01: Scope of the report PART 02: Research Methodology PART 03: Introduction • Market outline PART 04: Market landscape PART 05: Executive summary • Market overview • Five forces analysis PART 06: Market segmentation by product • Global conventional EP diagnostic catheters market • Global advanced EP diagnostic catheters market PART 07: Market segmentation by end-user • Hospitals • Diagnostic centers/EP labs • ASCs PART 08: Geographical segmentation • EP diagnostic catheters market in Americas • EP diagnostic catheters market in EMEA • EP diagnostic catheters market in APAC PART 09: Decision framework PART 10: Drivers and challenges • Market drivers • Market challenges PART 11: Market trends • Growing demand for steerable curve EP diagnostic catheters • Rising demand for EP mapping catheters • Emergence of EP diagnostic catheters with multi electrode tip configuration • Vendors' preference toward product bundling • Reprocessed EP diagnostic catheters PART 12: Vendor landscape • Competitive scenario PART 13: Key vendor analysis • St. Jude Medical • Boston Scientific • Biosense Webster • Medtronic • Biotronik • Other prominent vendors PART 14: Appendix • List of abbreviations List of Exhibits Exhibit 01: Global EP diagnostic catheters market 2016-2021 ($ millions) Exhibit 02: Five forces analysis Exhibit 03: Segmentation of global EP catheters market by product type Exhibit 04: Global EP diagnostic catheters market by product type 2016 and 2021 ($ millions) Exhibit 05: Global EP diagnostic catheters market by product type 2016 and 2021 (%) Exhibit 06: Global EP diagnostic catheters market by product type 2016 Exhibit 07: Advantages the fixed curve EP diagnostic catheters Exhibit 08: Advantages of EP steerable diagnostic catheters Exhibit 09: Global conventional EP diagnostic catheters market 2016-2021 ($ millions) Exhibit 10: Global advanced EP diagnostics catheters market 2016-2021 ($ millions) Exhibit 11: Global EP diagnostics catheters market by product type 2016-2021 ($ millions) Exhibit 12: Global EP diagnostics catheters market by product type 2016-2021 (%) Exhibit 13: Global EP diagnostic catheters market by end-users 2016 Exhibit 14: Total number of diagnostic centers in the US 2008-2013 Exhibit 15: Global EP diagnostic catheters market by geography 2016 (%) Exhibit 16: Global EP diagnostics catheters market by geography 2021 (%) Exhibit 17: Global EP diagnostic catheters market by geography 2016 & 2021 ($ millions) Exhibit 18: Global EP diagnostic catheters market by geography 2016 & 2021 (%) Exhibit 19: Global EP diagnostic catheters market by geography 2016 Exhibit 20: EP diagnostic catheters market in the Americas 2016-2021 ($ millions) Exhibit 21: EP diagnostic catheters market in EMEA 2016-2021 ($ millions) Exhibit 22: EP diagnostic catheters market in APAC 2016-2021 ($ millions) Exhibit 23: Global EP diagnostic catheters market by geography 2016-2021 ($ millions) Exhibit 24: Global EP diagnostic catheters market by geography 2016-2021 (%) Exhibit 25: MI versus open surgeries in developed nations 2016 (%) Exhibit 26: MI versus open surgeries in developing nations 2016 (%) Exhibit 27: Product recalls 2015-2017 Exhibit 28: Leading vendors ranking in global EP diagnostic catheters market 2016 Exhibit 29: Competitive structure analysis of global EP catheters market 2016 Exhibit 30: St. Jude Medical: Strength assessment Exhibit 31: St. Jude Medical: Strategy assessment Exhibit 32: St. Jude Medical: Opportunity assessment Exhibit 33: Boston Scientific: Key highlights Exhibit 34: Boston Scientific: Strength assessment Exhibit 35: Boston Scientific: Strategy assessment Exhibit 36: Boston Scientific: Opportunity assessment Exhibit 37: Biosense Webster: Key highlights Exhibit 38: Biosense Webster: Strength assessment Exhibit 39: Biosense Webster: Strategy assessment Exhibit 40: Biosense Webster: Opportunity assessment Exhibit 41: Medtronic: Key highlights Exhibit 42: Medtronic: Strength assessment Exhibit 43: Medtronic strategy assessment Exhibit 44: Medtronic: Opportunity assessment Exhibit 45: Biotronik: Strength assessment Exhibit 46: Biotronik: Strategy assessment Exhibit 47: Biotronik: Opportunity assessment

St. Jude Medical, Boston Scientific, Biosense Webster, Medtronic, Biotronik, Abbott, AngioDynamics, Cardiac Science, MicroPort Scientific, Siemens Healthcare, and Welch Allyn.